##fileformat = VCFv4.2
##fileDate = 2022-09-07
##reference = GRCh38
##INFO = <ID = cadd_scaled_20200411,Number = .,Type = String,Description = "The scaled CADD scores: PHRED-like (-10*log10(rank/total)) scaled C-score ranking a variant relative to all possible substitutions of the human genome (8.6x10^9). These scores range from 1 to 99. A cutoff for deleteriousness can be set to 10-15, but the choice remains arbitrary. version: v1.6, version date: 2020-04-11">
##INFO = <ID = clinvar_submissions,Number = .,Type = String,Description = "An & separated list of clinvar submissions. Format:interpretation|last_evaluated|review_status|submission_condition|submitter|comment">
##INFO = <ID = clinvar_summary,Number = .,Type = String,Description = "summary of the clinvar submissions">
##INFO = <ID = consensus_class,Number = 1,Type = Integer,Description = "The recent consensus classification by the VUS-task-force.">
##INFO = <ID = consensus_comment,Number = 1,Type = String,Description = "The comment for the consensus classification by the VUS-task-force.">
##INFO = <ID = consensus_date,Number = 1,Type = String,Description = "The submission date of the most recent consensus classification.">
##INFO = <ID = consequences,Number = .,Type = String,Description = "An & separated list of variant consequences from vep. Format:Transcript|hgvsc|hgvsp,consequence|impact|exonnr|intronnr|genesymbol|proteindomain|isgencodebasic|ismaneselect|ismaneplusclinical|isensemblcanonical">
##INFO = <ID = flossies_num_afr_20220325,Number = .,Type = String,Description = "Number of individuals with this variant in the african american cohort. (n = 2559) version: -, version date: 2022-03-25">
##INFO = <ID = flossies_num_eur_20220325,Number = .,Type = String,Description = "Number of individuals with this variant in the european american cohort. (n = 7325) version: -, version date: 2022-03-25">
##INFO = <ID = gnomad_ac_20211022,Number = .,Type = String,Description = "gnomAD alternate allele count for samples version: v3.1.2, version date: 2021-10-22">
##INFO = <ID = gnomad_af_20211022,Number = .,Type = String,Description = "gnomAD frequency of alternate allele in samples version: v3.1.2, version date: 2021-10-22">
##INFO = <ID = gnomad_het_20211022,Number = .,Type = String,Description = "gnomAD number of heterozygous individuals in samples version: v3.1.2, version date: 2021-10-22">
##INFO = <ID = gnomad_hom_20211022,Number = .,Type = String,Description = "gnomAD number of homozygous individuals in samples version: v3.1.2, version date: 2021-10-22">
##INFO = <ID = gnomad_popmax_20211022,Number = .,Type = String,Description = "gnomAD population with maximum allele frequency (AF) version: v3.1.2, version date: 2021-10-22">
##INFO = <ID = gnomad_popmax_AF_20211022,Number = .,Type = String,Description = "The allele frequency of the "popmax" population version: v3.1.2, version date: 2021-10-22">
##INFO = <ID = hexplorer_20220630,Number = .,Type = String,Description = "The HEXplorer delta score (HZEI mutant - HZEI wildtype). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO = <ID = hexplorer_mut_20220630,Number = .,Type = String,Description = "The HEXplorer score for the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO = <ID = hexplorer_rev_20220630,Number = .,Type = String,Description = "The HEXplorer delta score for the reverse complement of the original sequence (HZEI mutant rev - HZEI wildtype rev). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO = <ID = hexplorer_rev_mut_20220630,Number = .,Type = String,Description = "The HEXplorer score for the reverse complement of the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO = <ID = hexplorer_rev_wt_20220630,Number = .,Type = String,Description = "The HEXplorer score for the reverse complement of the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO = <ID = hexplorer_wt_20220630,Number = .,Type = String,Description = "The HEXplorer score for the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. version: 1.0, version date: 2022-06-30">
##INFO = <ID = max_hbond_20220630,Number = .,Type = String,Description = "The HBond delta score (max HBond mutant - max HBond wildtype). This score shows the change in binding affinity of the U1 snRNA to the splice site motiv, i. e. its ability to form hbonds with the sequence motiv. Negative values show that the mutant sequence is less probable to bind the U1 snRNA (This is a "worse" binding site). Positive values mean that the mutant sequence is more likely to bind the U1 snRNA. If there are multiple possible splice sites only the max values are considered. version: 1.0, version date: 2022-06-30">
##INFO = <ID = max_hbond_rev_20220630,Number = .,Type = String,Description = "The max HBond delta score for the reverse complement of the original sequence (HZEI mutant rev - HZEI wildtype rev). This score shows the change in binding affinity of the U1 snRNA to the splice site motiv, i. e. its ability to form hbonds with the sequence motiv. Negative values show that the mutant sequence is less probable to bind the U1 snRNA (This is a "worse" binding site). Positive values mean that the mutant sequence is more likely to bind the U1 snRNA. If there are multiple possible splice sites only the max values are considered. version: 1.0, version date: 2022-06-30">
##INFO = <ID = max_hbond_rev_mut_20220630,Number = .,Type = String,Description = "This is the max HBond score for the reverse complement of the mutant sequence. version: 1.0, version date: 2022-06-30">
##INFO = <ID = max_hbond_rev_wt_20220630,Number = .,Type = String,Description = "This is the max HBond score for the reverse complement of the reference sequence. version: 1.0, version date: 2022-06-30">
##INFO = <ID = max_hbond_wt_20220630,Number = .,Type = String,Description = "This is the max HBond score for the reference sequence. version: 1.0, version date: 2022-06-30">
##INFO = <ID = most_recent_consensus_scheme_classifications,Number = 1,Type = String,Description = "The most recent consensus scheme classification. Format:class|user|affiliation|date|chosen_criteria. The chosen criteria is a ~ separated list of critera itself. Format_criteria: criterium+strength+evidence.">
##INFO = <ID = phylop_100way_20131201,Number = .,Type = String,Description = "PhyloP 100 vertebrates (100-way) conservation scores. These scores measure evolutionary conservation at individual alignment sites. Interpretations of the scores are compared to the evolution that is expected under neutral drift. Positive scores: Measure conservation, which is slower evolution than expected, at sites that are predicted to be conserved. Negative scores: Measure acceleration, which is faster evolution than expected, at sites that are predicted to be fast-evolving.  version: -, version date: 2013-12-01">
##INFO = <ID = pubmed,Number = .,Type = String,Description = "An & separated list of pubmed ids relevant for this variant.">
##INFO = <ID = revel_20210503,Number = .,Type = String,Description = "The REVEL pathogenicity score of this variant. This score can range from 0 to 1, which reflects the number of trees in the random forest that classified the variant as pathogenic. Thus, higher values represent a more "certain" decision. When choosing a cutoff one should keep in mind that higher cutoffs will result in a higher specificity, but lower sensitivity. version: v1.3, version date: 2021-05-03">
##INFO = <ID = rsid_20220101,Number = .,Type = String,Description = "atests version: 0, version date: 2022-01-01">
##INFO = <ID = spliceai_details_20210907,Number = .,Type = String,Description = "Details about the SpliceAI predictions: These include delta scores (DS) and delta positions (DP) for acceptor gain (AG), acceptor loss (AL), donor gain (DG), and donor loss (DL). Format: GENE|DS_AG|DS_AL|DS_DG|DS_DL|DP_AG|DP_AL|DP_DG|DP_DL version: v1.3.1, version date: 2021-09-07">
##INFO = <ID = spliceai_max_delta_20210907,Number = .,Type = String,Description = "Max of delta scores for acceptor gain, acceptor loss, donor gain and donor loss. A value of 0.5 or more can be assumed to have an impact on splicing. version: v1.3.1, version date: 2021-09-07">
##INFO = <ID = task_force_protein_domain_20220601,Number = .,Type = String,Description = "The description of the protein domain from a hand-crafted table by the VUS-Task-Force. version: -, version date: 2022-06-01">
##INFO = <ID = task_force_protein_domain_source_20220601,Number = .,Type = String,Description = "The source of the task force protein domain. version: -, version date: 2022-06-01">
##INFO = <ID = user_classifications,Number = .,Type = String,Description = "Classifications by individual users of HerediVar. Format:class|user|comment|date">
##INFO = <ID = user_scheme_classifications,Number = .,Type = String,Description = "An & separated list of the variant scheme classifications from individual users. Format:class|user|affiliation|date|chosen_criteria. The chosen criteria is a ~ separated list of critera itself. Format_criteria: criterium+strength+evidence.">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
chr2	214730440	15	G	A	.	.	

phylop_100way_20131201 = 5.269;
cadd_scaled_20200411 = 24.3;
revel_20210503 = 0.104;
spliceai_details_20210907 = BARD1%7C0.00%7C0.00%7C0.00%7C0.01%7C46%7C-25%7C43%7C-29;
spliceai_max_delta_20210907 = 0.01;
gnomad_ac_20211022 = 1114;
gnomad_af_20211022 = 0.00732654;
gnomad_hom_20211022 = 15;
gnomad_het_20211022 = 1084;
gnomad_popmax_20211022 = eas;
flossies_num_afr_20220325 = 9;
flossies_num_eur_20220325 = 130;
rsid_20220101 = 3738999;
task_force_protein_domain_20220601 = BRCT_Domains;
task_force_protein_domain_source_20220601 = PMID:_32726901;
hexplorer_20220630 = -1.71;
hexplorer_mut_20220630 = 4.34;
hexplorer_wt_20220630 = 6.05;
hexplorer_rev_20220630 = -0.51;
hexplorer_rev_mut_20220630 = 7.99;
hexplorer_rev_wt_20220630 = 8.51;
max_hbond_20220630 = -4.50;
max_hbond_wt_20220630 = 4.50;
max_hbond_rev_20220630 = 0.00;
max_hbond_rev_mut_20220630 = 10.10;
max_hbond_rev_wt_20220630 = 10.10;
gnomad_popmax_AF_20211022 = 0.00984176;
clinvar_summary = criteria_provided,_conflicting_interpretations:Conflicting_interpretations_of_pathogenicity%7CUncertain_significance(1)%7C_Benign(8)%7C_Likely_benign(4);
clinvar_submissions = Benign|2021-02-25|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories|None&
	Likely_benign|2017-02-06|criteria_provided,_single_submitter|CN169374:not_specified|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|None&
	Likely_benign|2016-06-03|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Counsyl|None&
	Benign|2013-10-14|criteria_provided,_single_submitter|CN169374:not_specified|GeneDx|description:_This_variant_is_considered_likely_benign_or_benign_based_on_one_or_more_of_the_following_criteria:_it_is_a_conservative_change,_it_occurs_at_a_poorly_conserved_position_in_the_protein,_it_is_predicted_to_be_benign_by_multiple_in_silico_algorithms,_and/or_has_population_frequency_not_consistent_with_disease.&
	Benign|2020-12-04|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Invitae|None&
	Benign|2020-05-27|criteria_provided,_single_submitter|CN169374:not_specified|Genetic_Services_Laboratory,_University_of_Chicago|None&
	Likely_benign|2021-09-27|no_assertion_criteria_provided|C0027672:Hereditary_cancer-predisposing_syndrome|Institute_for_Biomarker_Research,_Medical_Diagnostic_Laboratories,_L.L.C.|None&
	Uncertain_significance|2018-07-02|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Mendelics|None&
	Benign|2014-06-26|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_This_alteration_is_classified_as_benign_based_on_a_combination_of_the_following:_population_frequency,_intact_protein_function,_lack_of_segregation_with_disease,_co-occurrence,_RNA_analysis,_in_silico_models,_amino_acid_conservation,_lack_of_disease_association_in_case-control_studies,_and/or_the_mechanism_of_disease_or_impacted_region_is_inconsistent_with_a_known_cause_of_pathogenicity.&
	Benign|2017-08-19|criteria_provided,_single_submitter|CN517202:not_provided|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|None&
	Likely_benign|2017-05-01|criteria_provided,_single_submitter|CN517202:not_provided|CeGaT_Praxis_fuer_Humangenetik_Tuebingen|None&
	Uncertain_significance|2015-02-01|no_assertion_criteria_provided|C2348819:Triple-Negative_Breast_Cancer_Finding|Lab._Molecular_Oncology,_VUB,_Free_University_of_Brussels|None&
	Likely_benign|None|no_assertion_criteria_provided|C0006142:Malignant_tumor_of_breast|Department_of_Pathology_and_Laboratory_Medicine,_Sinai_Health_System|description:_The_BARD1_p.Arg658Cys_variant_was_identified_in_9_of_2368_proband_chromosomes_(frequency:_0.004)_from_individuals_or_families_with_breast_and/or_ovarian_cancer_(Karppinen_2004,_Klonowska_2015,_Vahteristo_2006)._The_variant_was_also_identified_in_the_following_databases:_dbSNP_(ID:_rs3738888)_as_â€šÃ„ÃºWith_other_alleleâ€šÃ„Ã¹,_ClinVar_(6x,_as_benign_by_GeneDx,_Ambry_Genetics,_Invitae,_Color_Genomics.Inc,_and_as_likely_benign_by_Illumina_Clinical_Services,_Counsyl),_Clinvitae_(4x,_as_benign_and_likely_benign),_and_Zhejiang_Colon_Cancer_Database_(6x,_as_probably_pathogenic)._The_variant_was_not_identified_in_Cosmic_nor_MutDB_databases._The_variant_was_identified_in_control_databases_in_2270_(11_homozygous)_of_277098_chromosomes_at_a_frequency_of_0.008_in_the_following_populations:_Finnish_in_336_of_25784_chromosomes_(freq._0.013),_Latino_in_425_of_34414_chromosomes_(freq._0.012),_East_Asian_in_206_of_18868_chromosomes_(freq._0.01),_European_in_1067_of_126610_chromosomes_(freq._0.0084),_other_in_53_of_6462_chromosomes_(freq._0.008),_South_Asian_in_125_of_30782_chromosomes_(freq._0.004),_and_African_in_58_of_2403_chromosomes_(freq._0.0024),_increasing_the_likelihood_this_could_be_a_low_frequency_benign_variant_(Genome_Aggregation_Consortium_Feb_27,_2017)._Although_the_p.Arg658Cys_residue_is_not_conserved_in_mammals_and_other_organisms,_computational_analyses_(PolyPhen-2,_SIFT,_AlignGVGD,_BLOSUM,_MutationTaster)_suggest_that_the_variant_may_impact_the_protein._The_variant_occurs_outside_of_the_splicing_consensus_sequence_and_in_silico_or_computational_prediction_software_programs_(SpliceSiteFinder,_MaxEntScan,_NNSPLICE,_GeneSplicer,_HumanSpliceFinder)_do_not_predict_a_difference_in_splicing._There_are_conflicting_predictions_in_the_literature_regarding_the_clinical_significance_of_the_p.Arg658Cys_variant._Some_studies_refer_to_this_variant_as_potentially_pathological_(Klonowska_2015),_but_functional_studies_do_not_predict_clinical_significance_for_this_variant_although_it_is_in_a_functional_domain_(Lee_2015)._In_another_study_this_variant_has_been_utilized_as_putative_benign_polymorphism_in_multiple_functional_assays_(Sauer_2005)._A_co-occurring_pathogenic_BRCA1_variant_(c.709G>T,_p.Glu237X)_was_identified_in_1_individual_with_breast_cancer_by_our_laboratory,_increasing_the_likelihood_that_p.Arg658Cys_variant_does_not_have_clinical_significance._In_summary,_based_on_the_above_information_the_clinical_significance_of_this_variant_cannot_be_determined_with_certainty_at_this_time_although_we_would_lean_towards_a_more_benign_role_for_this_variant._This_variant_is_classified_as_likely_benign.&
	Benign|2016-11-22|criteria_provided,_single_submitter|CN169374:not_specified|PreventionGenetics,_PreventionGenetics|None&
	Benign|2014-11-11|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Health,_Inc|None&
	Likely_benign|2017-04-27|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Illumina_Laboratory_Services,_Illumina|description:_This_variant_was_observed_as_part_of_a_predisposition_screen_in_an_ostensibly_healthy_population._A_literature_search_was_performed_for_the_gene,_cDNA_change,_and_amino_acid_change_(where_applicable)._Publications_were_found_based_on_this_search._The_evidence_from_the_literature,_in_combination_with_allele_frequency_data_from_public_databases_where_available,_was_sufficient_to_determine_this_variant_is_unlikely_to_cause_disease._Therefore,_this_variant_is_classified_as_likely_benign.;
consequences = ENST00000260947|c.1972C>T|p.Arg658Cys|missense_variant|moderate|10|None|BARD1|1|0|0|1&
	ENST00000421162|c.619C>T|p.Arg207Cys|missense_variant|moderate|6|None|BARD1|1|0|0|0&
	ENST00000432456|c.70C>T|p.Arg24Cys|missense_variant|moderate|1|None|BARD1|0|0|0|0&
	ENST00000455743|c.*1592C>T|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|9|None|BARD1|0|0|0|0&
	ENST00000471590|n.307C>T|None|non_coding_transcript_exon_variant|modifier|2|None|BARD1|0|0|0|0&
	ENST00000613192|c.*35C>T|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|2|None|BARD1|0|0|0|0&
	ENST00000613374|c.562C>T|p.Arg188Cys|missense_variant|moderate|5|None|BARD1|1|0|0|0&
	ENST00000613706|c.1564C>T|p.Arg522Cys|missense_variant|moderate|10|None|BARD1|1|0|0|0&
	ENST00000617164|c.1915C>T|p.Arg639Cys|missense_variant|moderate|9|None|BARD1|1|0|0|0&
	ENST00000619009|c.433C>T|p.Arg145Cys|missense_variant|moderate|4|None|BARD1|1|0|0|0&
	ENST00000620057|c.*638C>T|None|3_prime_UTR_variant|modifier|9|None|BARD1|1|0|0|0&
	ENST00000650978|c.*2050C>T|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|9|None|BARD1|0|0|0|0&
	ENSR00001044281|None|None|regulatory_region_variant|modifier|None|None|None|None|None|None|None&
	NM_000465|c.1972C>T|p.Arg658Cys|missense_variant|moderate|10|None|BARD1|1|1|0|1&
	NM_001282543|c.1915C>T|p.Arg639Cys|missense_variant|moderate|9|None|BARD1|1|0|0|0&
	NM_001282545|c.619C>T|p.Arg207Cys|missense_variant|moderate|6|None|BARD1|1|0|0|0&
	NM_001282548|c.562C>T|p.Arg188Cys|missense_variant|moderate|5|None|BARD1|1|0|0|0&
	NM_001282549|c.433C>T|p.Arg145Cys|missense_variant|moderate|4|None|BARD1|1|0|0|0&
	NR_104212|n.1937C>T|None|non_coding_transcript_exon_variant|modifier|9|None|BARD1|0|0|0|0&
	NR_104215|n.1880C>T|None|non_coding_transcript_exon_variant|modifier|8|None|BARD1|0|0|0|0&
	NR_104216|n.1136C>T|None|non_coding_transcript_exon_variant|modifier|9|None|BARD1|0|0|0|0&
	XM_017004613|c.2071C>T|p.Arg691Cys|missense_variant|moderate|11|None|BARD1|0|0|0|0&
	XR_002959322|n.2162C>T|None|non_coding_transcript_exon_variant|modifier|11|None|BARD1|None|None|None|None;
pubmed = 25741868&
	29458332&
	32039725&
	16741161&
	19584272&
	26315354&
	19412175&
	31258718&
	16061562&
	20077502&
	9425226&
	15342711&
	16333312&
	25994375&
	26350354;
consensus_class = 3;
consensus_comment = 3;
consensus_date = 2022-07-27;
user_classifications = 1|Max_Mustermann|This_is_a_test_comment.|2022-09-07&
	4|Mirco_testtest|A_comment_4_U_UPDATE|2022-07-19&
	5|Marvin_Döbel|fwaeeaca|2022-06-03&
	4|Maria_Müller|This_is_another_test|2022-05-31;
user_scheme_classifications = 5|Max_Mustermann|testaffiliation|2022-09-07|ps2+ps+Evidence_for_ps2_given_in_this_field$ps1+ps+Evidence_for_ps1_given_in_this_field&
	5|Max_Mustermann|testaffiliation|2022-07-19|ps1+ps+abebra$pp1+pvs+VERRRYY_STRONG!$bp7+bp+fsafbadfasfwababetn_sgg_f_f_f&
	2|Mirco_testtest|sometest|2022-07-19|pp1+ps+aednr_hae_hrthztrj_zt_j_$bp4+bp+evonei_vbiuebiebgie_bie$bs2+bs+adbvebrag_g_g__&
	5|Max_Mustermann|testaffiliation|2022-07-21|ps1+ps+gdsgsgf$pp1+pm+suppporting_evidence$ps2+ps+ycavsvavasv&
	1|Max_Mustermann|testaffiliation|2022-07-27|4.4+ps+dsaaD$5.3+pvs+rhtrh$3.2+bp+asvabaerb__a_rg_af_a$2.8+pm+aga_raga_$1.1+pp+_aarfaeff_a__&
	4|Max_Mustermann|testaffiliation|2022-08-09|4.3+ps+gfsb;
most_recent_consensus_scheme_classifications = 5|Max_Mustermann|testaffiliation|2022-09-07|ps2+ps+Evidence_for_ps2_given_in_this_field$ps1+ps+Evidence_for_ps1_given_in_this_field&
	5|Max_Mustermann|testaffiliation|2022-07-19|ps1+ps+abebra$pp1+pvs+VERRRYY_STRONG!$bp7+bp+fsafbadfasfwababetn_sgg_f_f_f&
	2|Mirco_testtest|sometest|2022-07-19|pp1+ps+aednr_hae_hrthztrj_zt_j_$bp4+bp+evonei_vbiuebiebgie_bie$bs2+bs+adbvebrag_g_g__&
	5|Max_Mustermann|testaffiliation|2022-07-21|ps1+ps+gdsgsgf$pp1+pm+suppporting_evidence$ps2+ps+ycavsvavasv&
	1|Max_Mustermann|testaffiliation|2022-07-27|4.4+ps+dsaaD$5.3+pvs+rhtrh$3.2+bp+asvabaerb__a_rg_af_a$2.8+pm+aga_raga_$1.1+pp+_aarfaeff_a__&
	4|Max_Mustermann|testaffiliation|2022-08-09|4.3+ps+gfsb&
	3|Max_Mustermann|testaffiliation|2022-07-27|pp1+ps+fasdfasfas_testscht
